Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia

NCT06643130 · tracked via the Priya Life Science South Korea tracker

Sponsor

JW Pharmaceutical

Phase

Phase 3

Started

2024-12-02

Last updated

2025-09-09

Condition(s) studied

HypertensionDyslipidemia

Investigational drug(s) / intervention(s)

JW0104+C2402JW0104+C2403C2402

JW0104+C2402: For 8 weeks(PO (Per Oral), QD)

JW0104+C2403: For 8 weeks(PO, QD)

C2402: For 8 weeks(PO, QD)

Study summary

A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia

Eligibility

Sex

ALL

Min age

19 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients with hypertension and dyslipidemia Exclusion Criteria: * The subject not meet the specified msBP and LDL-C level

Primary outcome measure(s)

Change from baseline in msSBP (Systolic Blood Pressure) — week 8
Check msSBP
Percent change from baseline in LDL-C (Low-Density Lipoprotein Cholesterol) — week 8
Check LDL-C

Trial sites (1)

Facility	City	Region	Status
Gangdong Sacred Heart Hospital	Seoul	South Korea	Recruiting

More JW Pharmaceutical trials in South Korea

Glycemic Variability of Combination Therapies in T2DM Recruiting

Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study Recruiting

to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia Recruiting

To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers Recruiting

Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides Active, not recruiting

Other trials for the same condition

Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B Active, not recruiting

A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers Recruiting

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults Active, not recruiting

The Effect of Home Blood Pressure Measurement on the Management of Hypertension Active, not recruiting

Validation Study of CART BP as a Wearable Cuffless Blood Pressure Monitor Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06643130 on ClinicalTrials.gov ↗ ← All trials in South Korea